TAGLine 2025: A Year of Action
TAGLine 2025 documents a year of action as Treatment Action Group defended science, confronted attacks on public health, and fought to protect communities impacted by HIV, TB, and HCV.
Research Toward a Cure Trials
The December update of this listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry.
24 Hours to Save AIDS Research
On September 16 at 11 am (U.S.) savesaidsresearch.org starts a massive marathon to save AIDS funding.
Treatment Action Group Statement on Suspension of TB Funding Over White House Gain-of-Function Fictions
Treatment Action Group (TAG) opposes in the strongest possible terms the suspension of at least 22 TB research awards by the National Institutes of Health (NIH) following a May 2025 White House executive order banning “gain-of-function” research.
Congressional Briefing on Lifesaving NIH Infectious Disease Research
TAG was among thirteen organizations that cosponsored this Congressional briefing held on July 9, 2025. Briefing materials and presentations are available for download.
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
This publication discusses findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on, and the facilitators and barriers to potential long-acting therapies for Hepatitis C virus (HCV) cure currently being developed by the LONGEVITY consortium, funded by the global health agency Unitaid.
An Ethical and Legal Crisis: Treatment Action Group (TAG) Statement on the Withholding of NIH Funding for HIV Clinical Research Networks
TAG demands immediate action by the National Institutes of Health (NIH) to provide Congressionally appropriated and committed funding to the HIV clinical research networks (ACTG, HPTN, HVTN, IMPAACT).
U.S. Funding Cuts Threaten 39 Research Sites in South Africa Putting Scientific Advancements and Hard Won Progress Against TB and HIV at Risk
Lifesaving scientific research on prevention, testing, treatment and care for people living with HIV and tuberculosis (TB) in South Africa is under serious threat due to funding suspensions and grant terminations from the United States (US) government.
South Africa’s TB and HIV Research at Risk: A Call to Catalyze Urgent Action by Funders
Developed by TAG, Médecins Sans Frontières, and the South African Medical Research Council, this issue brief provides information about TB and HIV clinical trials and research programs impacted by U.S. government funding disruptions...
Hearing on Biomedical Research – Keeping America’s Edge in Innovation
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.